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Abstract
Background: fall-risk assessment with fall-prevention intervention referral for at-risk groups to avoid falls could be cost-
eﬀective from a care-payer perspective.
Aims: to model the cost-eﬀectiveness of a fall-risk assessment (QTUG compared to TUG) with referral to one of four fall-
prevention interventions (Otago, FaME, Tai Chi, home safety assessment and modiﬁcation) compared to no care pathway,
when the decision to screen is based on older age in a primary care setting for community-dwelling people.
Methods: a cohort-based, decision analytic Markov model was stratiﬁed by ﬁve age groupings (65–70, 70–75, 65–89,
70–89 and 75–89) to estimate cost per quality-adjusted life years (QALYs). Costs included fall-risk assessment, fall-prevention
intervention and downstream resource use (e.g. inpatient and care home admission). Uncertainty was explored using
univariate, bivariate and probabilistic sensitivity analyses.
Results: screening with QTUG dominates (>QALYs;<costs) screening with TUG irrespective of subsequent fall-prevention
intervention.eQTUG-based care pathways relative to no care pathway have a high probability of cost-eﬀectiveness in those
aged 75–89 (>85%), relative to those aged 70–74 (∼10< 30%) or 65–69 (<10%). In the older age group, only a 10% referral
uptake is required for the QTUG with FaME or Otago modelled care pathways to remain cost-eﬀective.
Conclusion: the highest probability of cost-eﬀectiveness observed was a care pathway incorporating QTUG with FaME
in those aged 75–89. Although the model does not fully represent current NICE Falls guidance, decision makers should
still give careful consideration to implementing the aforementioned care pathway due to the modelled high probability of
cost-eﬀectiveness.
Keywords: cost-eectiveness, falls, economic model, fall-risk screening, fall-prevention intervention, older people
Key points
• A care pathway including fall-risk assessment followed by fall-prevention intervention appears to have a high probability of
cost-eﬀectiveness in those aged 75–89 in this modelling analysis.
• e potential for cost-eﬀectiveness is dependent on type of fall-risk assessment and fall-prevention intervention used, as
well as the age-based cohort used for analysis.
• An injurious fall is estimated to occur 3 to 4 times more often in those aged 75-89 than those aged 65-74, which in part
drives the modeling results.
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M. Franklin and R.Hunter
• Basing screening on frailty rather than age may be a better initial predictor of an injurious fall relative to a generalised fall
in older people, but data for modelling purposes are currently lacking.
• Obtaining informative results from an economic model while appropriately controlling for the uncertainty around the
decision problem can be more cost-eﬀective than implementing a complex, multi-arm RCTs accounting for each care
pathway.
Introduction
e National Institute for Health and Care Excellence
(NICE) in 2013 estimated that falls in older adults cost the
UK’s National Health Service (NHS) around £2.3 billion
per year [1]. Up to 30% of adults aged 65+ years (i.e.
older people) are estimated to fall each year, rising to 50%
of those aged 80+ years [2]. Not all falls result in injury,
but the probability of a fall requiring medical attention
increases with age [3] and may result in declined levels of
physical functioning and social activities [4]. Technologies
and methods have been developed to screen for fall risk and
reduce risk and rate of falls, particularly in older people.
NICE Falls guidance states: individuals at risk of falling
should be given a multifactorial risk assessment followed by
a multifactorial intervention, which addresses risk factors
identiﬁed by the initial assessment [1].
For assessing fall risk, the timed up and go (TUG) test
is quick, simple and frequently used in clinical practice
worldwide to assess an individual’s balance and gait [1, 5].
A systematic review of TUG test eﬃcacy suggested it should
not be used on its own to predict fall risk, due to the high
number of false positives for people being at high fall risk [6].
An adapted version of the TUG test, the Quantitative Timed
Up and Go (QTUGTM), uses a statistical assessment of fall
risk and has already been shown to have improved sensitivity
and speciﬁcity compared to the TUG test [7, 8], for which
there is an NICE Medtech innovation brieﬁng report [9].
For fall prevention, a wide variety of community-based
interventions have been summarised and included in a 2012
Cochrane review (159 trials; 79,193 participants) focussed
on their eﬃcacy in relation to reducing risk and rate of falls
[2]. ese interventions can be broadly classiﬁed as inclusive
of exercise as a single intervention (59 trials) and multifacto-
rial programmes (40 trials), and included speciﬁc examples
such as multiple-component group or home-based exercise,
Tai Chi, multifactorial interventions including individual
risk assessment and home-safety assessment and modiﬁca-
tion interventions, among other interventions [2]. Cochrane
produced updated reviews of fall-prevention interventions
for community-dwelling people in 2018 (multifactorial and
multiple component interventions) [10] and 2019 (exercise)
[11], albeit with a diﬀerent perspective/grouping of the
interventions compared to Gillespie, Robertson [2].
e aim of this study is to evaluate the cost-eﬀectiveness
of a fall-risk assessment (QTUG compared to TUG) plus
a fall-prevention intervention as a ‘fall-related care pathway’
compared to each other care pathway and no care pathway
using a health economic decision model. Modelling has
been chosen as the most appropriate method to evaluate the
care pathways due to the various fall-risk assessment and
fall-prevention interventions, which need to be included.
is would not be feasible within a randomised controlled
trial (RCT) due to the large number of arms or com-
plex methodology such a trial would need. Instead, mod-
elling oﬀers a timely and cost-eﬀective method for providing
information to decision makers about the probability of
a speciﬁc care pathway being cost-eﬀective relative to an
alternative [12] and is recommended by the UK Medical
Research Council Complex Intervention Guidance (2006;
to be updated by 2019) [13], albeit the current model is a
necessary simpliﬁcation of the complexities around falls and
does not fully represent current NICE Falls guidance [1].
Methods
A decision analytic model was developed focussed on fall-
related care pathways; when fall-risk screening is conducted
in primary care, screening is oﬀered to community-dwelling
older people based on age and the suitability of the fall-
prevention interventions being provided in that age group
(i.e. aged 65–89 years; whereby the upper age limit is applied
for modelling purposes only). A Markov structure with a
one-year cycle period and ﬁve event states represent out-
comes associated with falling. e model was used to esti-
mate the impact of a fall-related care pathway on number
of fallers and falls, health service use (e.g. hospitalisation),
residential care admission and death. To explore the impact
of care-pathway eﬀectiveness, age-related characteristics, cost
and uptake on cost-eﬀectiveness, eight fall-based care path-
ways and no care pathway were modelled stratiﬁed by ﬁve
age groups with univariate and bivariate sensitivity analyses
conducted using a range of values for the modelled inter-
vention referral uptake, fall-risk screening eﬃcacy and utility
decrements.
Choice of modelled care pathways
e model was developed as part of the Perfect Patient
Pathway (PPP) Test Bed [14]. e QTUG device was used
to screen for fall risk within older people (e.g. aged 65+)
within primary care practices in the Sheﬃeld city region,
with subsequent referral to a fall-prevention intervention
if identiﬁed at high fall risk (i.e. statistical risk of falling
>70%). Further details on theQTUG and PPP can be found
elsewhere [14].
In the model, QTUG is compared to TUG as a com-
monly used fall-risk assessment test; however, it should be
noted that QTUG sensitivity and speciﬁcity data were based
on those at medium risk (i.e. statistical risk of falling >50%
[8]) and for TUG high risk (i.e. TUG score≥ 13.5 sec-
onds [6]) of falling, which is described as a limitation and
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Economic modelling of fall-related care
assessed in the univariate and probabilistic sensitivity analy-
ses (PSA). Modelled fall-prevention interventions included:
Otago home-based exercise, Falls Management group Exer-
cise programme (FaME) Tai Chi and home safety assessment
and modiﬁcation (HAM); which were all included in a
recent fall-based return-on-investment tool commissioned
by Public Health England [15]. All care pathways were
assessed against ‘no care pathway’ (i.e. no fall-risk assessment
nor fall-prevention intervention). Appendix S1 provides a
brief description of these assessments and interventions.
Model structure and assumptions
A two-part model structure included: (i) an initial decision
tree models the accuracy of the fall-risk assessment to inform
fall-prevention intervention referral and (ii) longer-term fall-
related events are captured using a state transition, cohort-
based Markov model with ﬁve event states, building on the
fall-related model by Poole, Smith [16] (see Appendix S2).
e ﬁve event states are as follows: (1) ‘well/insigniﬁcant
fall’—a person can be well or suﬀers an insigniﬁcant fall,
which has no eﬀect on quality of life and requires no addi-
tional care; (2) ‘minor fall: emergency department (ED)’—
minor fall requiring an ED visit; (3) ‘major fall: hospi-
talisation’—same as minor fall with subsequent inpatient
admission; (4) ‘long-term care’—care home admission; (5)
‘dead’—due to a fall, 1-year care-home-related or age-related
mortality. Transition probabilities were assigned to the like-
lihood of movement between event states. A decision tree
andMarkov state-transition schematic model are depicted in
Appendix S3. Model cycle period and time horizon is 1 and
2 years, respectively, due to limited trial evidence to suggest
any longer term intervention beneﬁt [2, 15].
is model is a necessary simpliﬁcation of the complexi-
ties around falls and does not fully represent current NICE
Falls guidance [1] (NICE checked these guidelines in May
2019 and are currently being updated), instead focussing
on speciﬁed screening with prevention interventions inde-
pendently based on available empirical evidence. A full list
of model assumptions is provided in Appendix S4. A key
assumption is that a person can only be referred to a fall-
prevention intervention if deemed at risk of fall by a fall-risk
assessment. Being referred to a fall-prevention intervention
in any other way or outside of a primary-care setting is not
modelled (e.g. an acute setting).
Model input parameter estimates
Transition probabilities, utilities and costs were sourced from
the empirical literature or other data sources (e.g. oﬃce for
national statistics), as presented and referenced in Table 1.
Transition probabilities
Transition probabilities represent the probability of moving
between the ﬁve states in the model per 1-year cycle period
as presented in the model schematic (Appendix S3). e
model accounts for the prevention interventions’ eﬃcacy for
reducing risk of being a faller (dependent on age) and rate
of falls (see Table 1), which aﬀects transition through the
model. e majority of transition probabilities are based on
observational data stratiﬁed by age groups (65–69, 70–74
and 75–89); parameterised using R (number of occurrences)
and N (sample size) [12].
Utilities
Health state utilities are used to represent a preference value
placed on a health state, where a value of 1 is considered
equivalent to ‘perfect health’ and 0 equivalent to ‘dead’. A
utility decrement reﬂects negative events (i.e. how an event
such as falling can negatively impact on a person’s preference-
based health state). ese are used to calculate quality-
adjusted life years (QALY) whereby the ‘quality adjustment’
is the utility value, and this is calculated over ‘life years’,
which is the amount of time spent in a health state. A
base-case utility value was used for the ‘well’ state based on
community dwelling older people aged 65 (i.e. youngest age
in the model) [17] to which age-related multipliers were
applied [18]. To conserve monotonicity in the PSA, state-
based utility decrements were applied, which included the
utility decrement of the less severe state(s) (see Table 1); e.g.
a major fall can never have a utility decrement lower than a
minor fall.
Costs
Care pathway costs were based on the PPP study implemen-
tation costs or sourced from Public Health England [15].
For the PSA, gamma distributions were ﬁtted at the unit
cost level (see Appendix S5). Care home costs are treated as
social care costs (as the costing perspective for care homes is
complex; e.g. if self, local authority or NHS funded) and so
modelled separately to healthcare (HC) costs.
Other model characteristics
As the model focuses on GP practice-based screening, it is
necessary to estimate the eligible practice population. e
number of patients per practice in England is estimated
at 7,685 people [19]. Assuming the age split in practices
is similar to the general population, of the total practice
population on average this equates to: 425 people (5.53%)
aged 65–69, 333 (4.34%) aged 70–74 and 557 (7.25%)
aged 75–89 [19]. ‘Base rate of falls for fallers’ (Table 1) is
estimated from Gillespie, Robertson [2] using control group
data for the parameters: ‘falls per person year’, ‘number in
analysis’ and ‘number of fallers’.
Base-case economic evaluation: cost per QALY
QALYs based on health-state utility values and costs, the
latter for a HC and health and social care (HSC) costing per-
spective, are estimated for the whole cohort rather than for an
individual. Head-to-head analyses are run whereby one care
pathway is compared to another care pathway (or no care
pathway) and incremental cost-eﬀectiveness ratios (ICERs)
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M. Franklin and R.Hunter
Table 1. Summary of decision tree and Markov model parameters
Variable Description or transition Age group Mean/[N] SE/[95%
CI]/(R, N)
Distribution Reference/comment
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Base-case model characteristics
Eligible people for risk assessment Average fall-risk assessment eligible
population per surgery (number of
people)
65–69 [425] N/A N/A Estimated: [19, 23]
70–74 [333] N/A N/A
75–89 [557] N/A N/A
Fallsa Base rate of falls for fallers 65–89 2.83 1.41 Gamma Estimated: [2]
Transition probabilities—decision tree
Percentage who fallb,c % who fall aged 65–69 65–69 0.144 0.01 Lognormal Estimated: [2, 3]
% who fall aged 70–74 70–74 0.184 0.02 Lognormal
% who fall aged 75–89 75–89 0.473 0.05 Lognormal
QTUGc Sensitivity 65-89 0.670 [0.53, 0.79] Beta [8]
Speciﬁcity 65–89 0.810 [0.63, 0.94] Beta
TUG Sensitivity 65–89 0.310 [0.13, 0.57] Beta [6]
Speciﬁcity 65–89 0.740 [0.52, 0.88] Beta
Otagod Reduced falling risk, RR 65–89 0.78 [0.64, 0.94] Beta [2]
Reduced falls rate, RaR 65–89 0.68 [0.58, 0.80] Beta
FaMEe Reduced falling risk, RR 65–89 0.85 [0.76, 0.96] Beta [2]
Reduced falls rate, RaR 65–89 0.71 [0.63, 0.82] Beta
Tai Chif Reduced falling risk, RR 65–89 0.80 [0.70, 0.91] Beta [11]
Reduced falls rate, RaR 65–89 0.81 [0.67, 0.99] Beta
HAMg Reduced falling risk, RR 65–89 0.88 [0.80, 0.96] Beta [2]
Reduced falls rate, RaR 65–89 0.81 [0.68, 0.97] Beta
Transition probabilities—Markov model
Well Well from following states: well,
minor fall, major fall
65–89 Remainder N/A N/A Remaining well is
dependent on any other
event not occurring
Minor fall Minor fall from following states: 65–69 0.024 (235.3, 10,000) Beta [3]
well, minor fall, major fall 70–74 0.028 (276, 10,000) Beta
75–89 0.058 (576.7, 10,000) Beta
Major fall Major fall from following states: 65–69 0.005 (52, 10,000) Beta [3]
well, minor fall, major fall 70–74 0.009 (91.9, 10,000) Beta
75–89 0.037 (368.6, 10,000) Beta
Long-term care Major fall from following states: 65–69 0.000 (0, 0) Beta [3]
major fall 70–74 0.086 (7.9, 91.9) Beta
75–89 0.274 (101.0, 368.6) Beta
Leave long-term care Well (leave long-term care) from:
long-term care
65–89 0.038 (106, 2544) Beta [24]
Fall-related death Dead (fall-related death) from: 65–69 0.040 (2.1, 52) Beta [3]
major fall 70–74 0.070 (6.4, 91.9) Beta
75–89 0.100 (36.9, 368.6) Beta
One-year mortality, long-term
care
Dead (one-year mortality) from:
long-term care (ﬁrst year only)
65–69 0.160 (144.8, 905) Beta [24, 25]
70–74 0.215 (669.7, 3115) Beta
75–89 0.289 (1350.5, 4673) Beta
Age-related death Dead (age-related death) from:
all states
Age-related
(yearly)
Not
presented
Not presented Beta [26]
Utilities—Markov states
Well Base-case well (aged 65 in base case);
base-case age-adjusted (not presented)
65 0.780 0.110 Beta Base case: [27]
Age-adjustment: [18]
Minor fallc ,h Utility decrement from well 65–89 0.025 0.003 Beta [28]
Major fallc , i Utility decrement from minor fall 65–89 0.073 0.007 Beta [28]
Long-term carec Utility decrement from major fall 65–89 0.096 0.010 Beta [16]
Dead Set utility value 65–89 0.000 N/A Beta N/A
Costs per person (£)—decision tree
QTUGc QTUG device and staﬀ (time and
training)
65–89 10.50 1.05 Gamma Set up cost: £2806 per
practice See Appendix S5.1
TUGc TUG test and staﬀ (time and
training)
65–89 7.50 0.75 Gamma Set up cost: £24 per
practice See Appendix S5.2
Otagoc Staﬀ (time, training, travel),
equipment and evaluation costs
65–89 441.33 44.13 Gamma [15] See Appendix S5.3
FaMEc Staﬀ (time, training, travel),
equipment, location, and evaluation costs
65–89 220.96 22.10 Gamma [15] See Appendix S5.3
(Continued)
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Economic modelling of fall-related care
Table 1. Continued
Variable Description or transition Age
group
Mean/
[N]
SE/[95%
CI]/(R, N)
Distribution Reference/
comment
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tai Chic Staﬀ (time, training, travel), equipment,
location, and evaluation costs
65–89 374.99 37.50 Gamma [15] See Appendix S5.3
HAMc Initial assessment, modiﬁcation, and
evaluation
65–89 247.41 24.74 Gamma [15] See Appendix S5.3
Cost per person (£)—Markov states
Well No event results in no resource-use 65–89 0 N/A N/A Assumed
Minor fall (cost per fall) Includes A&E attendance, ambulance, 65–69 421.74 See Appendix S5.4 Gamma [29, 30] Distribution
applied to unit costs (see
Appendices S5.4 & S5.5)
999 call (proportion also have 70–74 432.17 See Appendix S5.4 Gamma
GP or outpatient visit) 75–89 427.84 See Appendix S5.4 Gamma
Major fall (cost per fall) Includes A&E attendance, ambulance, 65–69 4047.77 See Appendix S5.4 Gamma [29, 30]
999 call, hospital inpatient (proportion 70–74 4023.05 See Appendix S5.4 Gamma Distribution applied to
unit costs
also have GP or outpatient visit) 75–89 4014.52 See Appendix S5.4 Gamma See Appendices
S5.4 & S5.5
Long-term carec Care home fee (per week = £480) 65–89 24,960.00 2496 Gamma [15] See Appendix S5.6
Dead Ambulance cost for conveying dead 65–89 236.44 33.62 Gamma [29]
Acronyms. FaME= Falls Management group Exercise programme; HAM=Home safety assessment and modiﬁcation; Otago =Otago home-based exercise;
QTUG=Quantitative Timed Up and Go device; TUG=Timed Up and Go test; RR =Risk Ratio; RaR =Rate Ratio.
Footnote. If the ‘Reference/comment’ is preceded by the word ‘Estimated’ then the ﬁgure presented is not a value obtained directly from the reference; rather,
it was used in a further calculation, for which more information about how the value was estimated is described in the manuscript (e.g. ‘Eligible people for risk
assessment’ and ‘Falls’) or as an additional table footnote (e.g. ‘Percentage who fall’ and ‘Falls’).
aCalculated across all studies with raw control group data available within Appendix 8 of Gillespie, Robertson [2] for the following parameters: ‘falls per person
year’, ‘number in analysis’, ‘number of fallers’.
bMean percentage of older people who fall per year estimated based on the assumption that one in ﬁve older people have an injurious falls per year as described
by Gillespie, Robertson [2]; these ﬁgures are ﬁve times the percentage of people who have an injurious fall by the speciﬁed age group based on those estimates
presented by Scuﬀham, Chaplin [3].
cStandard errors were not provided in the original paper or with the unit cost. In order to make this parameter probabilistic, the standard error around the point
estimate was assumed to be 10% of the mean.
dBased on those studies included as having an intervention described as ‘Multiple-component home-based exercise’ within Gillespie, Robertson [2].
eBased on those studies included as having an intervention described as ‘Multiple-component group exercise’ within Gillespie, Robertson [2].
fBased on those studies included as having an intervention described as ‘Tai Chi’ within Sherrington, Fairhall [11]. Only Tai Chi as an exercise-based intervention
could be updated to use the 2019 Cochrane review focussed on the use of exercise due to the fact that ‘Multiple-component home-based exercise’ and ‘Multiple-
component group exercise’ are not distinguished in the 2019 review.
gBased on those studies included as having an intervention described as ‘Home safety assessment and modiﬁcation intervention’ within Gillespie, Robertson [2].
his is the utility decrement estimated by iem, Klaaßen-Mielke [28] associated with ‘‘two or more falls’ (0.025).
iis is the utility decrement estimated by iem, Klaaßen-Mielke [28] associated with a ‘Fear of falling’ (0.073) brought on by the major relative to minor fall
during the fall cycle; note, the ‘minor fall’ utility decrement is also applied in the modelling analysis such that the cumulative utility decrement for a major fall is
0.98 (i.e. 0.025+ 0.073).
estimated. An ICER is the diﬀerence in costs divided by the
diﬀerence in beneﬁts (e.g. QALYs) between two alternatives.
Cost-eﬀectiveness is then evaluated in terms of the additional
cost per one additional unit of beneﬁt (i.e. QALYs). is
is then compared to a decision threshold such as NICE’s
willingness to pay (WTP) per additional QALY threshold
of £20,000 to £30,000 [20]; e.g. an ICER less than £30,000
(i.e. ICER < £30,000) would be considered cost-eﬀective
and an ICER above this would not be considered cost-
eﬀective. Also, a £0 WTP threshold is used whereby cost
savings are preferred to QALY gains.
e base-case assumes that everyone aged between 65 and
89 that is registered with a GP practice is eligible for fall-risk
screening and subsequent fall-prevention intervention. If a
person is identiﬁed at risk of falling, they will take the advice
of their GP and attend one of the modelled interventions
independently.
Probabilistic sensitivity analysis (PSA)
e uncertainty around cost and eﬀects was modelled by
ﬁtting appropriate distributions to estimates obtained from
the literature (Table 1) and were used in a Monte Carlo
simulation with 5,000 repetitions to model joint parameter
uncertainty as part of the PSA. A PSA is a random resampling
of the model parameters followed by a recalculation of the
ICER. e input parameter is not necessarily the point
estimate value (e.g. mean value), but rather it is a random
value from a pre-speciﬁed ﬁtted distribution to reﬂect the
range of possible values the parameter can take. is is then
done 5,000 times to try to capture the impact the uncertainty
of each parameter has on the probability that an intervention
is cost-eﬀective. Key results are presented as cost-eﬀectiveness
acceptability curves (CEACs) that plot the likelihood an
intervention is cost-eﬀective over a range of a WTP per
QALY thresholds (e.g. £20,000 to £30,000).
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Univariate and bivariate sensitivity analyses
In the univariate (i.e. changing one-point estimate input
parameter independently) and bivariate (i.e. changing two-
point estimate input parameters jointly) sensitivity analyses:
(i) uptake on fall-prevention intervention post-risk-screening
was varied from 100 (base case i.e. all people accept their
referral) to 75, 50, 25, 10 and 1%; noting that at 0%
no one receives intervention and no beneﬁts are observed;
(ii) QTUG sensitivity and speciﬁcity were independently or
jointly varied from 0.05 to 0.95 in 0.05 increments; noting
that 0 and 1 were not tested as these imply no or perfect
sensitivity and speciﬁcity, which was deemed improbable and
(iii) utility decrements were varied by 0.01 increments from
≈50 up to ≈200% the base-case value.
Results
Base-case analysis and PSA
As the QTUG-based care pathways dominate (>QALYS;
<cost) the TUG-based care pathways across all age-based
cohorts, only QTUG versus no-care-pathway results have
been presented here (see Appendices S6 and S7 for more
details). e cost-eﬀectiveness of the QTUG-based care
pathways relative to no care pathway is dependent on the
age of the cohort (see Table 2). If the QTUG-based care
pathway is provided to patients aged 75–89, it has a high
probability of being cost-eﬀective across all interventions
compared to no care pathway (a CEAC showing these results
are presented in Figure 1). Using the NICE upper threshold
(i.e. ICER < £30,000) for cost-eﬀectiveness, the QTUG-
based care pathways are not cost-eﬀective compared to no
care pathway for patients under the age of 75. If patients aged
65–74 are combined with those aged 75–89, a QTUG-based
care pathway can be cost-eﬀective dependent on subsequent
fall-prevention intervention, but at lower probabilities, than
for 75–89 alone.
An additional nine-way analysis comparing all care path-
ways simultaneously was conducted based on net monetary
beneﬁt (NMB), a description and associated results that are
presented in Appendix S8.
Univariate and bivariate sensitivity analyses
e ICERs (cost-eﬀectiveness, ICER < £30,000) at 10%
uptake of intervention post-QTUG-based referral compared
to no care pathway in those aged 75–89 were (see also
Appendix S9): FaME, dominates (>QALYs; <cost), Otago,
£24,035 (cost-eﬀective), HAM, £42,025 (not cost-eﬀective)
and Tai Chi, £43,900 (not cost-eﬀective).
Appendix S10 shows the matrix trade-oﬀ between relative
changes in QTUG sensitivity to speciﬁcity and subsequent
eﬀect on cost-eﬀectiveness compared to TUG or no care
pathway (focussing speciﬁcally on those aged 75–89 with
FaME). If QTUG and TUG sensitivity are equivalent (i.e.
both 0.31), QTUG compared to TUG produces lower costs
(equivalent QALYs) due to its higher speciﬁcity (0.81 versus
0.74), thus better ability to avoid additional cost of providing
fall-preventions intervention to non-fallers albeit with no
QALY gain; if QTUG and TUG speciﬁcity are equivalent
(i.e. both 0.74), QTUG still dominates TUG at a sensi-
tivity rate ≈0.35 (QTUG base-case sensitivity = 0.67). At a
sensitivity rate ≈0.45, QTUG dominates no care pathway
irrespective of speciﬁcity rate.
Appendix S11 shows the matrix trade-oﬀ between falls
and long-term-care-related utility decrements. If the base-
case utility decrements were increased to 200%, the QTUG-
based care pathways in those aged 65–74 would still not be
considered cost-eﬀective (i.e. ICER > £30,000).
Discussion
QTUG-based fall-risk screening and providing a fall-
prevention intervention to those identiﬁed as at fall risk is
cost-eﬀective compared to TUG-based screening. e cost-
eﬀectiveness of QTUG-based care pathways compared to no
care pathway is dependent on the age of the cohort screened
for fall-risk, with the most cost-eﬀective option to screen
only people aged 75–89 with referral to a fall-prevention
intervention for those identiﬁed at risk of falling.
e probability of a care pathway being cost-eﬀective
compared to no care pathway increases as the age of the
cohort increases because the modelled probability of an
injurious fall increases with age. is is an important factor
for consideration because if screening is based on age, the
suggestion is that you screen all people in this age group
(e.g. everyone aged 65–89) until you identify those at risk
of an adverse outcome (e.g. falling) followed by intervention
referral to avoid the adverse outcome; however, as four out
of ﬁve people who fall do not suﬀer an injury which requires
medical care (modelled as no utility decrement nor resources
used), many of these avoided falls have no QALY beneﬁt or
potential cost saving, as it is only one in ﬁve who have a fall
for whom a QALY gain and cost saving could be achieved.
Fall-related adverse events (e.g. injurious falls) do not seem to
occur enough in those aged 65–74 to warrant care-pathway
investment to avoid these events in the modelled analy-
sis, whereas these adverse events occur more often (around
3–4 times more often) in people aged 75–89 where the
care pathways have a high probability of being cost-eﬀective.
However, it should also be noted that there can be non-
injurious aspects of falls, for example fear of falling and
the accompanying negative aspects of social isolation and
inactivity. ese are not fully accounted for in the model,
as described below in section ‘Limitations’.
Chronological age though is potentially a poor diﬀeren-
tiating factor to use to identify those who would beneﬁt
from screening. Instead, frailty has been shown to be a better
predictor of mortality and variations in outcomes in older
age [21], with falls often considered as a deﬁcit associated
with frailty [22]. Although the QTUG can assess frailty [9],
primary-care-based frailty screening can be conducted using
the electronic Frailty Index (eFI) based on care record data
[22] (i.e. without the person present; noting this has its
limitations e.g. aspects such as current physical functioning
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Economic modelling of fall-related care
Table 2. Incremental deterministic and probabilistic cost-eﬀectiveness results: QTUG-based care pathway versus no care
pathway, by age group per practice
Intervention (QTUG-based
care pathway versus no care
pathway) & age group
Incremental results ICERs Prob. Cost-eﬀective
< λ (HC)
Prob. Cost-eﬀective
< λ (HSC)
HC costs HSC costs QALYs HC costs HSC costs λ = £0 λ = £20 kλ = £30 k λ = £0 λ = £20 k λ = £30 k
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
QTUG Otago
65–69 £38,873 £38,873 0.11 £364,277 £364,277 1% 2% 2% 1% 2% 2%
70–74 £25,769 £23,819 0.14 £186,160 £172,076 6% 8% 10% 7% 10% 11%
75–89 -£15,059 -£54,778 0.96 Dominates Dominates 49% 61% 66% 74% 84% 89%
65–89 £43,971 £2,302 1.21 £36,396 £1,906 29% 37% 41% 43% 53% 58%
70–89 £7,904 -£33,765 1.10 £7,176 Dominates 38% 47% 53% 58% 70% 75%
QTUG FaME
65–69 £17,321 £17,321 0.07 £238,055 £238,055 6% 8% 8% 6% 8% 8%
70–74 £8,649 £6,699 0.10 £87,368 £67,674 19% 24% 26% 23% 29% 32%
75–89 -£46,492 -£86,211 0.75 Dominates Dominates 74% 84% 88% 97% 99% 99%
65–89 -£26,134 -£67,803 0.92 Dominates Dominates 57% 66% 71% 80% 88% 91%
70–89 -£40,649 -£82,318 0.84 Dominates Dominates 66% 76% 81% 91% 95% 97%
QTUG Tai Chi
65–69 £35,924 £35,924 0.10 £370,309 £370,309 1% 1% 1% 1% 1% 1%
70–74 £25,004 £23,054 0.13 £196,640 £181,307 4% 6% 7% 5% 7% 8%
75–89 £1,346 -£38,373 0.90 £1,494 Dominates 40% 53% 60% 70% 82% 87%
65–89 £56,662 £14,994 1.13 £50,363 £13,327 21% 29% 34% 37% 48% 54%
70–89 £23,544 -£18,125 1.03 £22,901 Dominates 30% 40% 46% 52% 65% 71%
QTUG HAM
65–69 £24,279 £24,279 0.06 £417,121 £417,121 1% 2% 2% 1% 2% 2%
70–74 £16,125 £14,175 0.08 £196,427 £172,678 7% 9% 11% 9% 12% 14%
75–89 -£10,775 -£50,494 0.65 Dominates Dominates 49% 61% 67% 87% 93% 95%
65–89 £24,017 -£17,651 0.79 £30,287 Dominates 30% 38% 43% 53% 64% 69%
70–89 £2,544 -£39,125 0.73 £3,462 Dominates 39% 49% 55% 71% 81% 85%
Footnote. All results are presented at the cohort-level based on number of eligible people in an average primary care practice, rather than at the person-level.
Acronyms. FaME=Falls Management group Exercise programme; HAM=Home safety assessment and modiﬁcation; HC=Healthcare; HSC =Health & social
care; ICER = Incremental cost-eﬀectiveness ratio; Otago =Otago home-based exercise; QTUG=Quantitative Timed Up and Go device; TUG=Timed Up and
Go test; RR =Risk Ratio of falling; RaR =Rate Ratio of falls.
Definitions. Dominates =QTUG with intervention relative to no care pathway produces >QALYs and< costs (i.e. cost-eﬀective).
Symbols. λ =willingness to pay (WTP; £) per quality adjusted life year (QALY) thresholds; £20 & £30 k = £20,000 & £30,000.
cannot be assessed using the eFI, which can be using the
QTUG frailty assessment [9]); the eFI was considered within
the PPP, but no data were obtained for modelling purposes.
Basing screening on frailty rather than age may be a better
initial predictor of an injurious fall relative to a generalised
fall in older people, but data for modelling purposes are
currently lacking. ere are also other characteristics, which
could be considered as part of screening for fall-risk outlined
within NICE guidance, in particular a history of falls [1],
which could be included within a model. However, we
did not include these in our model due to: (i) the PPP
basing initial screening on age rather than history of falls for
practical reasons; (ii) known diﬃculties with identifying a
history of falls, as older people often do not report falls unless
they result in an injury requiring care and hence history of
falls can be imperfect; and (iii) identifying people at fall risk
based on a history of falls means that the ﬁrst fall cannot be
prevented as it has already occurred, and hence a key beneﬁt
of not basing fall risk on history of falls is the possibility of
preventing a ﬁrst fall. Despite the limitations of basing initial
screening on age followed by a fall-risk screening tool such as
QTUG, age tends to be more readily, reliably known relative
to history of falls and allows for the potential to avoid the
ﬁrst fall, which could lead to further falls. History of falls
could be combined with these other factors and modelled
when this evidence is available.
Limitations
ose wishing to use these modelling results as part
of evidence-based decision making should consider the
key model assumptions outlined in Appendix S4, also
noting that the model does not fully represent NICE Falls
guidance [1]. One key thing to note is that not all parameters
control for age-related characteristics. Speciﬁcally, fall-
prevention intervention eﬀectiveness was not stratiﬁed by
age cohorts within which eﬃcacy may diﬀer for various
age-related factors (e.g. muscle deterioration and ability to
beneﬁt from intervention; falls rate relative to injurious falls
and subsequent eﬀects on quality of life and care resources
consumed), which subsequently eﬀect cost-eﬀectiveness. As
such, this modelling analysis may under- or over-estimate
care-pathway cost-eﬀectiveness if intervention eﬃcacy is age
dependent, which is not transparent based on the 2012
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Figure 1. CEAC based on health and social care (HSC) costs for QTUG-based care pathway versus no care pathway (age-based
cohort: 75–89).
Cochrane review evidence [2]. However, the recent 2019
Cochrane review of exercise interventions [11] does present
some age-related sub-group analyses, but could not be used
for this analysis as it does not diﬀerentiate between group and
home exercise (but does include Tai Chi), which is needed
to diﬀerentiate between Otago and FaME as commonly
used, but diﬀerent (e.g. setting, eﬃcacy and cost) exercise
interventions; this is also the reason why Tai Chi eﬃcacy
evidence in the model is sourced from the 2019 review [11]
compared to Otago and FaME eﬃcacy sourced from the
2012 review [2]. Also noting, it is assumed that four in ﬁve
falls has no eﬀect on quality of life or care resource use;
however, non-injurious eﬀects related to even insigniﬁcant
falls (e.g. fear of falling) has quality of life implications, which
are not captured in this model other than for major falls
(which captures fear of falling as a utility decrement, applied
as an assumption), as there is no evidence to suggest what
proportion of fallers suﬀer from ‘fear of falling’. erefore,
the model may underestimate QALY gains from insigniﬁcant
and minor falls; although utility decrement values were
assessed in the univariate and bivariate analyses, which
suggested that the modelled utility decrements would have
to greatly increase (>200% base-case) to aﬀect potential for
a care pathway to move from being considered not cost-
eﬀective to cost-eﬀective. It is also assumed that the eﬃcacy
of the fall-risk assessment and fall-prevention intervention
are independent of each other, which may not be true.
e QTUG sensitivity and speciﬁcity data source has two
key limitations: (1) it is based on one main study of QTUG
sensitivity and speciﬁcity conducted by the manufacturer
(i.e. Kinesis Health Technologies Ltd) [8] and as a result
may be biased [9]; (2) the study was based on medium risk
of falling (i.e. statistical risk of falling >50%; note, high
risk >70%) and for the TUG, this was based on high risk
(i.e. TUG score≥ 13.5 s). To account for these limitations,
we speciﬁed eﬃcacy uncertainty associated with QTUG in
the PSA and assessed a change in QTUG sensitivity and
speciﬁcity estimates on subsequent cost-eﬀectiveness results
in the univariate analysis (see Appendix S10); in both cases,
QTUG eﬃcacy would need to decrease closer to TUG
eﬃcacy to be considered comparatively not cost-eﬀective due
to the small diﬀerence in per-person screening and sunk cost.
Conclusion
e QTUG fall-risk assessment with FaME fall-prevention
intervention had the highest probability of cost-eﬀectiveness
when primary-care-based screening was conducted in
community-dwelling people aged 75–89. Despite lim-
itations and the fact the model does not fully rep-
resent current NICE Falls guidance, decision makers
should give careful consideration to implementing the
aforementioned care pathway due to the high proba-
bility of cost-eﬀectiveness identiﬁed from the modelling
analyses.
Supplementary data: Supplementary data mentioned in
the text are available to subscribers in Age and Ageing online.
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